INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.42, sa.4, ss.959-964, 2010 (SCI-Expanded)
To report the long-term follow up of patients with locally advanced bladder cancer treated with either adjuvant chemotherapy with gemcitabine/cisplatin (GC) or methotrexate, vinblastine, epirubicin, and cisplatin (MVEC) or no additional treatment after radical cystectomy, to examine various survival endpoints and factors associated with long-term survival.